Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/h3HRvWGUj5A
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/h3HRvWGUj5A
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at: https://youtu.be/WHu05hmExBY
- Arabic version of this lecture is available at: https://youtu.be/GIvZjcq2Eis
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/i_bUFU-p43Q
Arabic Language version of this lecture is available at:
https://youtu.be/RaIP09m4XMY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/AtiaKPIdzAQ
Arabic Language version of this lecture is available at:
https://youtu.be/2cwyPcRDGEY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/XRD-QqGFP18
- Arabic version of this lecture is available at:
https://youtu.be/c9PoavAtNKM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/V3UGzJTwAWw
- Arabic version of this lecture is available at:
https://youtu.be/hGLaUde2ue4
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/kanEHVsStsI
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at: https://youtu.be/WHu05hmExBY
- Arabic version of this lecture is available at: https://youtu.be/GIvZjcq2Eis
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/i_bUFU-p43Q
Arabic Language version of this lecture is available at:
https://youtu.be/RaIP09m4XMY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/AtiaKPIdzAQ
Arabic Language version of this lecture is available at:
https://youtu.be/2cwyPcRDGEY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/XRD-QqGFP18
- Arabic version of this lecture is available at:
https://youtu.be/c9PoavAtNKM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/V3UGzJTwAWw
- Arabic version of this lecture is available at:
https://youtu.be/hGLaUde2ue4
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/kanEHVsStsI
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
I hope this presentation will highlight the most updated researches about fasting and different renal disorders. I try to collect all the researches in one presentation. i hope it will be of value in our clinical practice
CẬP NHẬT ĐIỀU TRỊ VIÊM GAN VIRUT MAN NĂM 2017Great Doctor
Viêm gan (Hepatitis) là tổn thương tại gan với sự có mặt của các tế bào bị viêm trong mô gan. Tình trạng bệnh có thể là tự khỏi hoặc có thể phát triển tới việc gây sẹo tại gan. Viêm gan cấp tính là khi bệnh chỉ kéo dài dưới 6 tháng, còn viêm gan mãn tính là khi bệnh kéo dài hơn. Hầu hết các trường hợp tổn thương gan trên thế giới là do một nhóm các virus, được gọi là các virus viêm gan, gây ra. Viêm gan còn có thể là do chất độc (tiêu biểu là rượu), các nhiễm trùng khác, hoặc từ quá trình tự miễn dịch (autoimmune). Bệnh có thể diễn biến chỉ với các triệu chứng rất nhẹ hoặc không có triệu chứng và người bệnh không cảm thấy ốm. Người bệnh cảm thấy các triệu chứng khi bệnh làm ảnh hưởng đến các chức năng của gan, trong đó có loại bỏ các chất độc hại, điều tiết thành phần máu, và tiết dịch mật hỗ trợ tiêu hóa.
After this presentation, you should be able to:
Critically evaluate the scientific rationale regarding dietary Na+, P, K+, and fluid restrictions in HD patients, and why these restrictions may be misguided.
Better communicate with HD patients and clinic staff the nuances of these dietary restrictions.
Promote efficacious physical activity programs for hemodialysis patients.
14. a case study on diabetes mellitus type 1 with diabetic ketoacidosis cp in...Dr. Ajita Sadhukhan
A 26 year old male patient was admitted to the male medicine ward with complaints of nausea, vomiting, generalised weakness, anxiety, decreased appetite, headache since noon.
What Spine Surgeons Need to Know About Dietary Strategies for Heart Disease a...James McCarter
Presentation to the North American Spine Society Annual Meeting. Interdisciplinary Spine Forum: Obesity and Diabetes: Impact on the Spine and Evidence-Based Management Strategies. Organized by Dr. Carrie Diulus
Diabetes and obesity have reached epidemic proportion. It is imperative that spine providers take these factors into consideration. We also have the opportunity to be powerful motivators to our patients with some straight forward evidence-based strategies.
Upon completion of this session, participants should gain strategies to:
Understand impact of metabolic syndrome on spine conditions/degeneration and treatment outcomes
Learn dietary strategies to have a positive impact on these conditions and the most current science behind these recommendations
Understanding the impact of strategies on heart disease and lipids
How to implement recommendations in a busy clinical setting
Multidisciplinary case chronic myelogenous leukemia in pregnancyDR MUKESH SAH
Pregnancy and CML
While pregnancy in and of itself does not affect the course of CML, there is a risk for maternal disease progression if CML remains untreated for the duration of pregnancy. Unfortunately, treatment of CML during pregnancy is complicated due to the teratogenic nature of TKIs
13. a case study on convulsions in a kco epilepsy with lactational amenorrhoeaDr. Ajita Sadhukhan
A 25 year old female patient was admitted to the female medicine ward with complaints of 2 and a half month amenorrhoea, epileptic fit convulsions at home, vertigo, generalised weakness and 1 episode of epileptic fit today evening.
A presentation by Max Bell at the 2017 meeting of the Scandinavian Society of Anaestesiology and Intensive Care Medicine.
All available content from SSAI2017: https://scanfoam.org/ssai2017/
Delivered in collaboration between scanFOAM, SSAI & SFAI.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Fasting ramadan & kidney disease
1. Ramadan Fasting &
kidney disease
Yousef BOOBES, MD, CES, FASN
Consultant Nephrologist
Tawam Hospital, Al Ain - UAE
Al Ain February 26,2021
Ramadan Fasting in Patient with Chronic Illness - Workshop
2. Outline
• Introduction
• Medical Aspect
• Effect of fasting on kidney diseases
• Islamic Aspect
• The definition of a disease that permits breaking the fasting
• Our advise to our renal patients
4. Fasting during Ramadan
• It is the forth pillar of Islam and most Muslims are strictly
adhering to it
• The sick patients are exempted
• Most of Muslim with renal diseases is very keen to observe the
fast
5. Our advise to patients to fast or not to fast is
considered a “Fatwa”
• To give a correct “Fatwa” you need two elements:
• Medical knowledge:
Effects of fasting on kidney diseases
• Islamic knowledge:
The definition of the disease that permits break fasting
9. Methods & Patients
• Prospective observational study (Ramadan 1426 à Oct- Nov 2005)
• Fasting time was ~ 12.5 h
• Inclusion criteria were:
• Transplanted for more than one year
• Stable kidney function
• Voluntary chose to observe the fast
• Exclusion criteria were any acute illness
Boobes Y, et al. SJ Kid Dis Transpl. 2009;20(2):198–200
10. Methods & Patients
• 22 kidney transplant recipients completed the study
• 10 males and 12 females
• Mean age was 47±11.6 (25-69) years
• eGFR (MDRD) ml/mim/1.73m2, (Mean±SD)
• 16 pts >50
• 6 pts GFR ≤50
• Blood and urine samples were taken just before “Iftar”
• Comorbid conditions were
• Hypertension: 20 pts
• Dyslipidemia: 9 pts
• Diabetes mellitus 5 pts
Boobes Y, et al. SJ Kid Dis Transpl. 2009;20(2):198–200
11. Results - Clinical Parameters
Boobes Y, et al. SJ Kid Dis Transpl. 2009;20(2):198–200
0
20
40
60
80
100
120
140
Weight BPs BPd
p= NS p= NS
p= NS
Pre
Post
During
Pre
Post
During
Pre
Post
During
13. Results - Others
PRE
Mean ± SD
DURING
Mean ± SD
POST
Mean ± SD
Pre-
Dur
p
Pre-
Post
P
Uric Acid mmol/l 0.4 ± 0.1 0.38 ± 0.08 0.39 ± 0.08 0.1 0.4
Na mmol/l 139 ± 3.3 137 ± 3.95 138 ± 2.5 0.18 0.37
K mmol/l 4.2 ± 0.4 4.3 ± 0.5 4.2 ± 0.4 0.3 0.8
HCO3 mmol/l 25 ± 2.9 25 ± 3.4 25 ± 3 0.9 0.4
Albumin 36 ± 3.4 36 ± 3.3 37 ± 3.8 0.7 0.02
Hemoglobin 11.9 ± 2.97 12.9 ± 1.5 13 ± 1.9 0.23 0.17
Boobes Y, et al. SJ Kid Dis Transpl. 2009;20(2):198–200
14. Results – Others
PRE
Mean ± SD
DURING
Mean ±
SD
POST
Mean ± SD
Pre-
Dur
p
Pre-
Post
P
T. Choles mmol/l 5.04 ± 1.11 5.1 ± 1.2 5.03 ± 0.83 0.39 0.07
HDL mmol/l 1.03 ± 0.31 1 ± 0.27 1.05 ± 0.25 0.85 0.42
LDL mmol/l 3.3 ± 1.08 3.37 ± 1.02 3.08 ± 0.96 0.07 0.8
TG mmol/l 1.71 ± 0.62 1.34 ± 0.43 1.59 ± 0.44 0.0011 0.7
Boobes Y, et al. SJ Kid Dis Transpl. 2009;20(2):198–200
15. Conclusion
• It is safe for a kidney recipient to fast Ramadan after
one year & they have stable kidney functions
• It is in agreement with other studies
Boobes Y, et al. SJ Kid Dis Transpl. 2009;20(2):198–200
17. Patients & Methods
• Prospective observational cohort study
• 31 pts
• 19 male, 12 female
• CKD III 14, CKD IV 12, CKD V five
• 19 suffering from diabetes, 22 from HTN
• Mean age 54.0±14.2 years
Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. SJ Kid Dis Transpl. 2010;21:898–902
18. Results - Clinical
• The fasting time (Ramadan 1426 H) was around 12.5 h
• All patients managed to fast the whole of the month
of Ramadan
• Non of them had any undue clinical manifestation
Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. SJ Kid Dis Transpl. 2010;21:898–902
19. Clinical Parameters
PRE
Mean ± SD
DURING
Mean ± SD
POST
Mean ± SD
P Value
Weight kg 76.4 ± 18 75 ± 17.6 75.7 ± 18 0.13
SBP mmHg 138 ± 13.2 133.2 ± 15 131 ± 26.3 o.21
DBP mmHg 81.3 ± 9 78.2 ± 9.3 80 ± 10 0.6
Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. SJ Kid Dis Transpl. 2010;21:898–902
20. Electrolytes
PRE
Mean ± SD
DURING
Mean ± SD
POST
Mean ± SD
P Value
Na
mmol/l
133.8±23 137±3 138±3 NS
K
mmol/l
4.7±0.6 4.8±0.7 4.8±0.6 NS
HCO3 mmol/l 22.5±3.9 24.2±4 23±3.7 NS
Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. SJ Kid Dis Transpl. 2010;21:898–902
21. Renal Function
PRE
Mean ± SD
DURING
Mean ± SD
POST
Mean ± SD
P Value
S. Creatinine
µmol/l
245±128 238±109 237±127 0.17
Urea
mmol/l
13.4±8 12.6±6 14±7.4 NS
Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. SJ Kid Dis Transpl. 2010;21:898–902
23. DM Control & Hemoglobin
PRE
Mean ± SD
DURING
Mean ± SD
POST
Mean ± SD
P Value
Glucose
mmol/l
8±3 13.4±8 11.2±16 0.27
Hb A1c
%
6.8±1.4 6.7±1.8 7.4±2 NS
Hb
g/dl
12±1.5 12±1.7 12±1.6 NS
Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. SJ Kid Dis Transpl. 2010;21:898–902
24. Urinary Protein Excretion
PRE
Mean ± SD
DURING
Mean ± SD
POST
Mean ± SD
P Value
Proteinuria
g/l
1.7±2.3 1.4±1.8 1.6±1.7 NS
Prot/creat
mg/mg
2±2.6 2±3 2.4±3.1 0.11
Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. SJ Kid Dis Transpl. 2010;21:898–902
25. Conclusion
• Fasting Ramadan is safe in patients with CKD (stage
III – V)
Bernieh B, Al Hakim MR, Boobes Y, Abu Zidan FM. SJ Kid Dis Transpl. 2010;21:898–902
27. Patients & Methods
• 65 patients with CKD stage III-V , mean age of 53 years
• Fasted for 15 h/d in Riyadh in the summer of 2015
• Clinical and biochemical data were collected
• within the 3 months before Ramadan
• after fasting for at least 10 days
• 3months after Ramadan.
Bakhit et al. Saudi Med J 2017; Vol. 37 (1): 48-52
28. Results
• 22 pts (33.8%) developed WRF
• 15 patients developed WRF during Ramadan
• 7 patients in 3 m after Ramadan
• 8 later improved, 14 continued (20.5%)
• Risk factors:
• More advanced CKD stage
• Higher baseline systolic BP
• Younger age
• Improvement in mean systolic BP & HbA1C à post-Ramadan
Bakhit et al. Saudi Med J 2017; Vol. 37 (1): 48-52
29. Conclusion
• Ramadan fasting during the summer months was associated
with worsening of renal function
Bakhit et al. Saudi Med J 2017; Vol. 37 (1): 48-52
30. Results
• Mean serum creatinine (SD)
• 206 μmol/l (88) before Ramadan
• 214 μmol/l (37) during Ramadan
• 209 μmol/l (101) 3 months after fasting
Bakhit et al. Saudi Med J 2017; Vol. 37 (1): 48-52
32. eGFR in CKD Patients
Before & After Ramadan
Bragazzi NL. Int J Nephrol Renovasc Dis. 2015 Jun 1; 8:53-57
p=0.99
33. eGFR in CKD Patients
Before & After Ramadan
Bragazzi NL. Int J Nephrol Renovasc Dis. 2015 Jun 1; 8:53-57
p=0.73
34. eGFR in CKD Patients
Before & After Ramadan
Bragazzi NL. Int J Nephrol Renovasc Dis. 2015 Jun 1; 8:53-57
p=0.66
35. Journal of Research in Medical Sciences
Bragazzi NL. J Res Med Sci. 2014 Jul;19(7):665-76.
36.
37. Ramadan and Urolithiasis
• 1,262 pts have been studied
• Ramadan fasting does not
• deteriorate health condition in subjects with renal colic
• does not cause hypercalciuria
• does not impair the balance between lithogenic promotors
(oxalate, Ca++, uric acid, phos) and inhibitors (citrate, Mg++)
Bragazzi NL. J Res Med Sci. 2014 Jul;19(7):665-76.
38. Ramadan and chronic kidney disease
• Summarizing all the studies:
• 140 subjects with CKD have been investigated:
• 40 on hemodialysis
• 18 on peritoneal dialysis (PD)
• 15 on predialysis
• 67 on pharmacological treatment
Bragazzi NL. J Res Med Sci. 2014 Jul;19(7):665-76.
39. Ramadan and chronic kidney disease
• Most studies did not find any differences between
before and after Ramadan fasting
• Bernieh et al. found improvements during the fasting
and after
• 3 studies presented mixed evidences of an increased
risk for fasting patients during Ramadan, and 3 clear
negative evidences
Bragazzi NL. J Res Med Sci. 2014 Jul;19(7):665-76.
40. Ramadan and kidney transplant
• 463 pts who received kidney transplant have been
investigated
• Biochemical parameters do not change significantly
• No rejection or deterioration of KF were observed
• One author reported of adverse effects due to
cyclosporine toxicity, acute rejection episodes, and
urinary infections
Bragazzi NL. J Res Med Sci. 2014 Jul;19(7):665-76.
41. CONCLUSIONS
• There are no evidences that Ramadan is injurious for
patients with CKD willing to fast, even though
further high quality research is welcome.
Bragazzi NL. J Res Med Sci. 2014 Jul;19(7):665-76.
45. The Fiqh Encyclopedia
The definition of a disease that permits breaking the fasting
• A disease that increases with fasting
• If the pt fears that the disease will increase by fasting, or if it is not harmful but difficult; He may
break his fast. It is the doctrine/view of the majority of scholars : Hanafi, Maliki and Hanbali
• A disease that harmed by fasting with fears of perishing
• If the disease harms the fasting person, and he fears death because of it; Break fast is obligatory
• This is the doctrine of the majority: Hanafi, Maliki, and Shafi’i, and a group of Hanbali
• A mild disease
• A disease in which fasting does not affect, or it is not harmful - such as easy headache or a toothache –
• it is not permissible to break his fast, and this is according to the agreement of the four fiqh schools
47. In general, Fasting Ramadan is good for health
• Fasting Ramadan has many Social, Psychological & Physical
Health Benefits
• May promote insulin sensitivity: …
• May promote healthy guts: which in turn aids immune and digestive
processes
• Can help lower of blood sugar & cholesterol
• Increasing boost of will power.
48. In general, Fasting Ramadan is good for health
• (ex.) A study at the University of Texas conducted on the
effects of intermittent fasting, found that it
• reduces inflammation
• improves blood lipids
• helps in weight loss
• Participants did not reduce their total calories – just the time frame
in which they consumed them
Tinsley GM, et al. Effects of intermittent fasting on body composition. Nutr Rev. 2015 Oct;73(10):661-74.
49. In general, Fasting Ramadan is good for health
• Fasting Ramadan has many Social, Psychological &
Physical Health Benefits
• Increasing boost of will power.
• A Study demonstrated that fasting Ramadan have been
effective in diminishing stress, anxiety, and depression
levels (statistically significant)
• ..
Koushali AN, et al. Iran J Nurs Midwifery Res. 2013;18(3):232-236.
51. Doctor Will Give the Advice “Fatwa” to Patient
• The ruling on fasting of Ramadan for Kidney disease
patients varies from obligation to allowable to
forbidden, depending on the severity of the disease
and the effect of fasting
52. Rule of Fasting
• Stable vs unstable or acutely ill
• All studies looked on the effect of fasting in stable
patients
53. Rule of Fasting
• CKD stage I and stage II
• They fast Ramadan as healthy
• CKD stage III
• CKD IIIa: They could not fast but fasting would be better
• CKD IIIb: They could not fast and this would be better
• CKD stage IV and stage V (pre dialysis)
• They could not fast (preferable & we encourage them to not fast)
• if they choose to fast – it should be done under medical supervision
• If they develop significant worsening of kidney function (>25%) due to fasting à
become forbidden
54. Rule of Fasting
• ESRD on Hemodialysis
• Dialysis days: It is allowable to not fast (highly recommended)
if HD done during the day
• They will be very weak
• HD breaks fasting (in one fatwa), and it does not (in other one)
• Some ask to switch to night shift
• Other days: It is allowable to not fast
55. Rule of Fasting
• Transplant patients (CKD TII-TIII):
• It is allowable to not fast.
• Fasting during the 1st 6 months post op strongly
discouraged and could be forbidden
• If they missed Sahoor’s IS doses, they should break
fast and take these medications
56. If kidney disease patient choose to fast à
he should do it under close observation à
General Recommendations
57. General Recommendations
• CKD stage I to V
• They should drink enough fluids during the night with much diet
control
• They are not working outdoor (under the sun)
• Check s. creatinine before fasting and 7 days after the
beginning of the fast, especially If eGFR <20.
• If stayed stable, they can continue their fast;
• otherwise they should break their fast
58. General Recommendations
• Transplant patients:
• They could attempt fasting providing that they drink enough fluids during
the night with much diet control
• They are not working outdoor (under the sun)
• Cyc/Tac trough level should be checked before they break fast
• It is advisable to check s. creatinine before fasting and within 7 days after
the beginning of the fast. If it is not stable, pt should break their fast.
• Consider switching pt from Prograf to Advagraf before Ramadan
• Fasting Ramadan during summer in some northern countries might be
impossible -à forbidden